Total Funding
6
Total FundingSeries B raised
Growth Score
pts
Heat Score
-11 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
716324
Okairos AG is a biopharmaceutical company focused on the discovery and development of genetic T-cell vaccines, including hepatitis C virus.
Alfredo Nicosia: Co-Founder & CSO
Antonella Folgori: Chief Executive OfficerPast Role: Okairos, Director, Immunology & Co-Founder
About the Company
Okairos AG, a bio-pharmaceutical company, focuses on the discovery and development of genetic T-cell vaccines, including hepatitis C virus. The company also provides health and allied services. It has operations in Rome and Naples, Italy.
The company is based in Basel, Switzerland. Okairos AG was former subsidiary of Istituto Di Ricerche Di
Biologia Molecolare P. Angeletti Spa.
